I have a theory. Now I might be off base, I don't think so but here it goes. Is anyone familiar with the name Geno Auriemma, Italian born, moved to America, learned english discovered basketball and played in high school. As a coach working his way through the ranks of high school then small colleges as an asst. coach where no one believed in his coaching style till he got the opportunity at a no name school called Uconn in 1985 since then he became the most dominate women's basketball coach. Others Collage teams doubting that they had a chance against their domination on the court in the late 80's and early 90's and that was the case. The big question of the day was "Is Geno good for women's basketball?" Well as the years have past I think the answer is most definitely "YES"! Because of Uconn's dominance other schools have had to pick up the pace and had to become more and more competitive and if you have watched any of the last few years of women's March Madness the level of play and the competition has made for a much better fan experience.

Now, compare that to CYDY. We are at a precipice of the new drug world where once we get an approval for any indication we could and most likely will turn the pharmaceutical market upside down. We could potentially run the gamut for awhile. But with that being said I believe the likes of Pfizer's, Gilead, Moderna and J&J will not go away but will have to pick up the pace and find a way to become more competitive and produce drugs that will actually work and not just sustain and prolong life but actually improve life as we know it for a better life experience.

So my question to you. Is CYDY and Leronlimab good for the Pharmaceutical market and the future of Pharmaceuticals? I say "YES"!